Cervarix Passes Safety Hurdles; FDA Ponders Breadth of Protection Claim

GlaxoSmithKline surmounted the final safety hurdles for its human papillomavirus vaccine Cervarix at a landmark September 9 FDA advisory committee review of the adjuvanted product